Lee Ichia / staff reporter
Moderna’s COVID-19 bivalent vaccine has had about 450,000 doses, and as eligibility was expanded yesterday, the Central Epidemic Command Center (CECC) may order more if many are willing to receive the jab. said that there is
Moderna’s bivalent vaccine targets the original SARS-CoV-2 strain and the Omicron BA.1 subtype.
Centers for Disease Control and Prevention (CDC) Deputy Director Zhuang Renxiang, a spokesman for the CECC, said 1,319 children aged 6 months to 4 years were vaccinated against COVID-19 on Monday, the first in their age group. said he received a second vaccine. – Achieve vaccination coverage of 40.8% and 11.9% respectively.
Photo: Shuyuan Tsai, Taipei Times
He said 11,163 people received Moderna’s bivalent boosters on Sunday, bringing the total number of doses given to more than 449,000.
Eligibility for the bivalent vaccine has been expanded to include people between the ages of 18 and 49 who received their last dose of the COVID-19 vaccine at least 3 months (84 days) ago.
Vice Minister of Health and Welfare Wang Yisheng, who heads the CECC, said there are still about 2.55 million doses of the bivalent vaccine in stock.
After the eligibility is expanded, the center will monitor people’s willingness to get vaccinated and decide whether to order additional shots, Wang said.
When asked if people between the ages of 18 and 49 could receive a second booster dose that is not the bivalent COVID-19 vaccine, Chuang said the center was not aware of vaccination policies in other countries. We said we were collecting data, but our recommendations differ.
The data were submitted yesterday to the Advisory Committee on Immunization (ACIP) for review.
Last Friday, a meeting was held at the Department of Health and Human Services to expand the eligibility for government-funded prescriptions of the traditional herbal formula used to treat COVID, Seikwan Ichigo (清官一號), or NRICM101. We discussed the proposal to -19 developed in Taiwan.
On the 15th, the Ministry of Health, Labor and Welfare reduced the number of groups eligible for prescriptions.
Yesterday, CDC Deputy Director Philip Lo said conference attendees reached a tentative conclusion: eligibility would include COVID-19 patients with any of four conditions. should be expanded.
They include postpartum women whose health status has been assessed by a physician of traditional Chinese medicine, and those with mild symptoms and risk factors for any of unstable high blood pressure, peptic ulcer bleeding, or psychiatric illness. It is included.
The exact date of implementation is unknown as the necessary procedures are underway, but the Center will try to resolve the matter as soon as possible.
Comments are moderated. Please keep your comments relevant to the article. Statements containing abusive and obscene language, personal attacks of any kind or promotions will be removed and users will be banned.The final decision is at the discretion of Taipei Times.
https://www.taipeitimes.com/News/taiwan/archives/2022/10/12/2003786871 Bivalent jab orders dependent on capture, according to CECC